Endonovo Therapeutics, Inc. (ENDV)
OID · Healthcare · Biotechnology
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Quarterly Financials
| Metric | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -1.00 | 0.00 | 0.00 |
| Operating Income | -388K | -360K | -231K | -247K |
| Net Income | -697K | -669K | -533K | -558K |
| Diluted EPS | $nan | $nan | $0.00 | $nan |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 73K | 135K | 140K | 10K |
| Gross Profit | 58K | 125K | 132K | 3K |
| Operating Income | -2.2M | -3.3M | -2.9M | -1.6M |
| Net Income | -3.1M | -18.5M | 6.9M | -2.8M |
| Diluted EPS | $-0.05 | $-0.13 | $0.01 | $0.00 |